trending Market Intelligence /marketintelligence/en/news-insights/trending/dv2itbtjbv1qpd8tsxbocg2 content esgSubNav
In This List

UK's Tiziana Life Sciences plans US IPO

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes

Blog

Investment Banking Essentials Newsletter April Edition - 2022


UK's Tiziana Life Sciences plans US IPO

London-based Tiziana Life Sciences PLC is planning a U.S. IPO of its American depositary shares.

The biotechnology company has applied to list its ADSs, representing ordinary shares, on the Nasdaq Capital Market under the symbol TLSA.

Tiziana said its shares will continue to trade on the AIM, a market of the London Stock Exchange.

The company said the offering will be priced at a later date.

Laidlaw & Company (UK) Ltd. is acting as the representative of the underwriters in the offering.